(Q44288306)

1 December 2017

title

Efficacy and safety of pravastatin vs simvastatin after cardiac transplantation (English)

1 reference

1 December 2017

1 reference

Keogh A

1

1 reference

1 December 2017

Macdonald P

2

1 reference

1 December 2017

Kaan A

3

1 reference

1 December 2017

Aboyoun C

4

1 reference

1 December 2017

Spratt P

5

1 reference

1 December 2017

Mundy J

6

1 reference

1 December 2017

publication date

1 June 2000

1 reference

The Journal of Heart and Lung Transplantation

1 December 2017

published in

1 reference

1 December 2017

volume

19

1 reference

1 December 2017

issue

6

1 reference

1 December 2017

page(s)

529-537

1 reference

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900077-2

7 January 2021

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900077-2

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900077-2

7 January 2021

The Australian and New Zealand Cardiothoracic Organ Transplant Registry: first report 1984-1992

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900077-2

7 January 2021

Effect of pravastatin on outcomes after cardiac transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900077-2

7 January 2021

Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900077-2

7 January 2021

Long-term clinical tolerance of lovastatin and simvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900077-2

7 January 2021

Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in transplant patients: are the statins mechanistically similar?

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900077-2

7 January 2021

Accumulation of lovastatin, but not pravastatin, in the blood of cyclosporine-treated kidney graft patients after multiple doses

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900077-2

7 January 2021

Plasma concentration profiles of simvastatin 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitory activity in kidney transplant recipients with and without ciclosporin

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900077-2

7 January 2021

Differential sensitivity of C2-C12 striated muscle cells to lovastatin and pravastatin

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900077-2

7 January 2021

Rhabdomyolysis from the coadministration of lovastatin and the antifungal agent itraconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900077-2

7 January 2021

Coadministration of itraconazole with hypolipidemic agents may induce rhabdomyolysis in healthy individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900077-2

7 January 2021

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900077-2

7 January 2021

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900077-2

7 January 2021

Apparent discontinuation rates in patients prescribed lipid-lowering drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900077-2

7 January 2021

10.1016/S1053-2498(00)00077-2

Identifiers

DOI

1 reference

1 December 2017

1 reference